Circular and Fusion RNAs in Medulloblastoma Development
Overview
Authors
Affiliations
The cerebellar cancer medulloblastoma is the most common childhood cancer in the brain. . RNA sequencing of 81 human biospecimens of medulloblastoma using pipelines to detect circular and fusion RNAs. Validation via PCR and Sanger sequencing. 27, 56, 28 and 11 RNA circles were found to be uniquely up-regulated, while 149, 7, 20 and 15 uniquely down-regulated in the SHH, WNT, Group 3, and Group 4 medulloblastoma subtypes, respectively. Moreover, linear and circular fusion RNAs containing exons from distinct genes joined at canonical splice sites were also identified. These were generally expressed less than the circular RNAs, however the expression of both the linear and the circular fusions was comparable. Importantly, the expression of the fusions in medulloblastoma was also comparable to that of cerebellum. A significant number of fusions in tumor may be generated by mechanisms similar to the ones generating fusions in normal tissue. Some fusions could be rationalized by read-through transcription of two neighboring genes. However, for other fusions, e.g., a linear fusion with an exon from a downstream gene joined 5' to 3' with an exon from an upstream gene, more complicated splicing mechanisms, e.g., trans-splicing, have to be postulated.
Architects and Partners: The Dual Roles of Non-coding RNAs in Gene Fusion Events.
Dorney R, Reis-das-Merces L, Schmitz U Methods Mol Biol. 2024; 2883:231-255.
PMID: 39702711 DOI: 10.1007/978-1-0716-4290-0_10.
Martinez de Estibariz I, Jakjimovska A, Illarregi U, Martin-Guerrero I, Gutierrez-Camino A, Lopez-Lopez E Cancers (Basel). 2023; 15(19).
PMID: 37835380 PMC: 10571996. DOI: 10.3390/cancers15194686.
Webster J, Mai H, Ly A, Maher C Bioinformatics. 2023; 39(9).
PMID: 37707537 PMC: 10516643. DOI: 10.1093/bioinformatics/btad569.
Skitchenko R, Dinikina Y, Smirnov S, Krapivin M, Smirnova A, Morgacheva D Front Oncol. 2023; 12:1085947.
PMID: 36713498 PMC: 9877404. DOI: 10.3389/fonc.2022.1085947.
Paret C, Ustjanzew A, Ersali S, Seidmann L, Jennemann R, Ziegler N Cancers (Basel). 2022; 14(24).
PMID: 36551537 PMC: 9775636. DOI: 10.3390/cancers14246051.